2-Hydroxyglutarate inIDHmutant Acute Myeloid Leukemia: Predicting Patient Responses, Minimal Residual Disease and Correlations With Methylcytosine and Hydroxymethylcytosine Levels

Leukemia and Lymphoma - United Kingdom
doi 10.3109/10428194.2012.701009

Related search